Copyright
©2014 Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Dec 16, 2014; 2(12): 769-786
Published online Dec 16, 2014. doi: 10.12998/wjcc.v2.i12.769
Published online Dec 16, 2014. doi: 10.12998/wjcc.v2.i12.769
New targeted therapies for breast cancer: A focus on tumor microenvironmental signals and chemoresistant breast cancers
Armel Hervé Nwabo Kamdje, Richard Simo Tagne, Jeremie Mbo Amvene, Department of Biomedical Sciences, Faculty of Sciences, University of Ngaoundéré, PO Box 454, Ngaoundéré, Cameroon
Paul Faustin Seke Etet, Lorella Vecchio, Department of Basic Health Sciences, College of Applied Medical Sciences, Qassim University, Buraydah 52571, Saudi Arabia
Jean-Marc Muller, Université de Poitiers, Faculté des Sciences, Pôle Biologie-Santé Bât B36, 1, rue Georges Bonnet-BP633, 86022 Poitiers cedex, France
Mauro Krampera, Department of Medicine, Section of Hematology, Stem Cell Research Laboratory, University of Verona, 37129 Verona, Italy
Kiven Erique Lukong, Department of Biochemistry, College of Medicine, University of Saskatchewan, Saskatoon S7N 5E5, Canada
Author contributions: All authors contributed to this paper.
Correspondence to: Armel Hervé Nwabo Kamdje, PhD, Department of Biomedical Sciences, Faculty of Sciences, University of Ngaoundere, PO Box 454, Ngaoundere, Cameroon. armel.nwabo@gmail.com
Telephone: +237-90-190421 Fax: +237-22-251747
Received: May 30, 2014
Revised: July 12, 2014
Accepted: September 23, 2014
Published online: December 16, 2014
Processing time: 202 Days and 13.8 Hours
Revised: July 12, 2014
Accepted: September 23, 2014
Published online: December 16, 2014
Processing time: 202 Days and 13.8 Hours
Core Tip
Core tip: Emerging therapeutic targets may overcome chemoresistance in breast cancer.